|
Apr 16
|
Johnson & Johnson Shows Focus On Strengthening Its Business Upon Its Consumer Health Unit Spinoff
|
|
Apr 16
|
Johnson & Johnson (JNJ) Q1 2024 Earnings Call Transcript
|
|
Apr 16
|
Johnson & Johnson Q1 Earnings Top Wall Street Estimates On Strong Medical Devices Sales, Drugmaker Boosts Annual Outlook
|
|
Apr 16
|
Building Permits Come in Lower Than Expected
|
|
Apr 16
|
J&J (JNJ) Q1 Earnings Beat Estimates, Sales Miss, MedTech Soft
|
|
Apr 16
|
J&J CFO on Q1 Earnings, Forecast and Product Pipeline
|
|
Apr 16
|
CORRECTING and REPLACING Johnson & Johnson Reports Q1 2024 Results
|
|
Apr 16
|
Housing Numbers Shrink as Q1 Earnings Heat Up: BAC, JNJ, UNH
|
|
Apr 16
|
Johnson & Johnson reports mixed Q1 earnings, narrows guidance
|
|
Apr 16
|
Johnson & Johnson (JNJ) Reports Q1 Earnings: What Key Metrics Have to Say
|
|
Apr 15
|
Big Bank earnings, March housing data: What to Watch
|
|
Apr 15
|
WHO warns of falsified cough syrup ingredients seized in Pakistan
|
|
Apr 15
|
Johnson & Johnson Reports Earnings Tuesday. What to Expect.
|
|
Apr 15
|
Should You Buy Johnson & Johnson (JNJ) Ahead of Earnings?
|
|
Apr 15
|
CORRECTED-UPDATE 3-Tanzania, Rwanda, Zimbabwe join African recall of J&J cough syrup
|
|
Apr 15
|
5 U.S. Bigwigs Likely to Gain on Q1 Earnings Beat This Week
|
|
Apr 15
|
Rwanda joins other African countries in recalling J&J children's cough syrup
|
|
Apr 13
|
UPDATE 1-South Africa recalls J&J's cough syrup sold in six African nations after suspected toxicity
|
|
Apr 13
|
South Africa recalls J&J's cough syrup sold in six African nations after suspected toxicity
|
|
Apr 12
|
Johnson & Johnson (JNJ) Stock Moves -0.85%: What You Should Know
|